| Pleiotropic effects of statins: new therapeutic targets in drug design O Bedi, V Dhawan, PL Sharma, P Kumar Naunyn-Schmiedeberg's archives of pharmacology 389, 695-712, 2016 | 193 | 2016 |
| Role of vitamins and minerals as immunity boosters in COVID-19 P Kumar, M Kumar, O Bedi, M Gupta, S Kumar, G Jaiswal, V Rahi, ... Inflammopharmacology 29 (4), 1001-1016, 2021 | 175 | 2021 |
| Animal models of hepatotoxicity GS Bhakuni, O Bedi, J Bariwal, R Deshmukh, P Kumar Inflammation Research 65, 13-24, 2016 | 67 | 2016 |
| Molecular and pathological events involved in the pathogenesis of diabetes-associated nonalcoholic fatty liver disease O Bedi, S Aggarwal, N Trehanpati, G Ramakrishna, P Krishan Journal of clinical and experimental hepatology 9 (5), 607-618, 2019 | 61 | 2019 |
| Herbal Induced Hepatoprotection and Hepatotoxicity: A Critical Review. O Bedi, KRV Bijjem, P Kumar, V Gauttam Indian journal of physiology and pharmacology 60 (1), 6-21, 2016 | 50 | 2016 |
| Investigations on acute oral toxicity studies of purpurin by application of OECD guideline 423 in rodents O Bedi, P Krishan Naunyn-Schmiedeberg's archives of pharmacology 393 (4), 565-571, 2020 | 41 | 2020 |
| Role of microbiota in pathogenesis and management of viral hepatitis R Sehgal, O Bedi, N Trehanpati Frontiers in Cellular and Infection Microbiology 10, 341, 2020 | 36 | 2020 |
| Carbohydrate restriction ameliorates nephropathy by reducing oxidative stress and upregulating HIF-1α levels in type-1 diabetic rats P Krishan, G Singh, O Bedi Journal of Diabetes & Metabolic Disorders 16, 1-10, 2017 | 27 | 2017 |
| Anti-hyperalgesic and anti-nociceptive potentials of standardized grape seed proanthocyanidin extract against CCI-induced neuropathic pain in rats G Kaur, O Bedi, N Sharma, S Singh, R Deshmukh, P Kumar Journal of basic and clinical physiology and pharmacology 27 (1), 9-17, 2016 | 27 | 2016 |
| Molecular and pathobiological involvement of fetuin-A in the pathogenesis of NAFLD O Sardana, R Goyal, O Bedi Inflammopharmacology 29 (4), 1061-1074, 2021 | 26 | 2021 |
| Combined effect of hydrogen sulphide donor and losartan in experimental diabetic nephropathy in rats M Kaur, S Sachdeva, O Bedi, T Kaur, P Kumar Journal of Diabetes & Metabolic Disorders 14, 1-10, 2015 | 23 | 2015 |
| Rodent animal models: from mild to advanced stages of diabetic nephropathy M Kaur, O Bedi, S Sachdeva, BVKK Reddy, P Kumar Inflammopharmacology 22, 279-293, 2014 | 21 | 2014 |
| Hepatoprotective activity of morin and its semi-synthetic derivatives against alcohol induced hepatotoxicity in rats GS Bhakuni, O Bedi, J Bariwal, P Kumar Indian J Physiol Pharmacol 61 (2), 175-190, 2017 | 16 | 2017 |
| In vitro targeted screening and molecular docking of stilbene, quinones, and flavonoid on 3T3-L1 pre-adipocytes for anti-adipogenic actions O Bedi, S Aggarwal, N Trehanpati, G Ramakrishna, AS Grewal, P Krishan Naunyn-Schmiedeberg's Archives of Pharmacology 393, 2093-2106, 2020 | 15 | 2020 |
| Mechanistic and physiological approaches of fecal microbiota transplantation in the management of NAFLD M Gupta, P Krishan, A Kaur, S Arora, N Trehanpati, TG Singh, O Bedi Inflammation Research 70, 765-776, 2021 | 13 | 2021 |
| Impact of diet restriction in the management of diabetes: Evidences from preclinical studies P Krishan, O Bedi, M Rani Naunyn-Schmiedeberg's Archives of Pharmacology 391, 235-245, 2018 | 13 | 2018 |
| Pathobiological and molecular connections involved in the high fructose and high fat diet induced diabetes associated nonalcoholic fatty liver disease Ekta, M Gupta, A Kaur, TG Singh, O Bedi Inflammation Research 69, 851-867, 2020 | 12 | 2020 |
| Fatty acid synthase inhibition ameliorates diabetes induced liver injury in rodent experimental model O Bedi, N Srivastava, D Parsad, P Krishan European Journal of Pharmacology 901, 174078, 2021 | 7 | 2021 |
| Regulatory requirements for medical devices: an insight O Bedi, P Krishan, G Singh Applied Clinical Research, Clinical Trials and Regulatory Affairs 4 (1), 16-25, 2017 | 6 | 2017 |
| Metabolomic analysis shows dysregulation in amino acid and NAD+ metabolism in palmitate treated hepatocytes and plasma of non-alcoholic fatty liver disease spectrum S Aggarwal, V Yadav, R Maiwall, A Rastogi, V Pamecha, O Bedi, ... Biochemical and Biophysical Research Communications 643, 129-138, 2023 | 5 | 2023 |
